Hematopoietic stem and progenitor cells (HSPCs) have been documented to be specified from hemogenic endothelial (HE) cells in the ventral wall of the dorsal aorta (DA) through the endothelial-to-hematopoietic transition (EHT) during mouse embryogenesis [1] . N 6 -methyl-adenosine (m 6 A) is the most prevalent mRNA modification in eukaryotes. Although the function of m 6 A modification in cell fate determination of embryonic stem cells has been recently reported [2] , the physiological role and the underlying mechanism of m 6 A modification in definitive hematopoiesis during mouse embryogenesis have not been reported yet. Due to the early lethality of mutant mice with conventional knockout of methyltransferase like 3 (Mettl3) [2] , one of the most important m 6 A methyltransferase catalytic subunits identified so far [3] , here we utilized Vec-Cre mice crossed with Mettl3 fl/fl mice to deplete the expression of Mettl3 specifically in endothelial cells of mouse aorta-gonad-mesonephros (AGM) region.
First, the knockout efficiency of Mettl3 in endothelial cells of Vec-Cre; Mettl3 fl/fl AGM was validated by multiple approaches. The expression of Mettl3 in the whole AGM was significantly decreased at both protein and mRNA levels ( Figure 1A ; Supplementary information, Figure S1A ). The obvious decrease of Mettl3 in endothelial cells of AGM was also confirmed by immunofluorescence (Supplementary information, Figure S1B ). Then the developmental hematopoietic phenotype was examined. Interestingly, the expression of Runx1 and Gfi1, both specifically expressed in the intra-aortic hematopoietic cluster and essential for HSPC development [4, 5] , was decreased in E10.5 Vec-Cre; Mettl3 fl/fl AGM ( Figure 1B ). This is consistent with the reduced number of Runx1 + cells and hematopoietic clusters by immunofluorescence ( Figure 1C ). In addition, the proportion of HSPCs (CD34 + c-Kit + ) in the E10.5 Vec-Cre; Mettl3 fl/fl AGM was apparently attenuated as compared to that in the control ( Figure 1D ). Figure S1D ). Meanwhile, we also examined the percentage of pre-HSCs, the maturation of which is required for the formation of definitive HSCs [6] . Intriguingly, the proportion of pre-HSCs (CD144 + C-D45 Figure S1G ). Finally, to determine whether endothelial-specific loss of Mettl3 affects the function of HSPC, we performed the colony-forming unit culture (CFU-C) assay as well as transplantation assay. As shown in Figure 1F and 1G, the colony formation ability and the short-term reconstitution capability of HSPCs in the E10.5 Vec-Cre; Mettl3 fl/fl AGM were diminished, suggesting that the function of HSPC was also impaired. Nevertheless, HSPCs functioned normally in the E10.5 Vav-Cre; Mettl3 fl/fl AGM (Supplementary information, Figure S1H and S1I). Taken together, these data demonstrate that Mettl3 in endothelial cells of AGM plays a pivotal role in HSPC development during mouse definitive hematopoiesis.
Our recent data showed that Mettl3-mediated m 6 A modification on notch1a mRNA could repress the arterial-endothelial Notch activity to promote HSPC specification in zebrafish [7] . Furthermore, previous studies in zebrafish and mouse showed that the inhibition of Notch signaling in HE cells facilitated EHT and enhanced the generation of HSPCs [8, 9] . To determine whether Notch signaling pathway is regulated by Mettl3 during mouse definitive hematopoiesis, we performed RNA-seq using 
the E10.5 control and Vec-Cre; Mettl3
fl/fl AGM. In total, 457 upregulated and 652 downregulated genes were identified in the Vec-Cre; Mettl3 fl/fl AGM ( Figure 1H ). As expected, among the upregulated ones, genes that encode components of Notch signaling pathway were highly enriched ( Figure 1I ). The gene-set enrichment analysis (GSEA) also revealed a marked upregulation of genes in Notch signaling pathway (Supplementary information, Figure S2A ). Furthermore, the majority of mRNA transcripts of these genes involved in Notch signaling pathway contained m 6 A modifications (Supplementary information, Figure S2B ), suggesting that m 6 A might play an important regulatory role in Notch signaling activity. Among these m A-modified genes, we found that Hes5, Dtx4, Dll3, Dll1, Mfng and Nocth1 were remarkably upregulated upon Mettl3 deficiency (Supplementary information, Figure S2C ). Similar to the m 6 A methylation of notch1a mRNA in zebrafish [7] , we also identified conserved m 6 A peak near the stop codon of Notch1 mRNA ( Figure 1J ). In addition, m 6 A-RIP-qPCR assay showed that the enrichment of m 6 A on Notch1 mRNA was notably decreased in the E10.5 Vec-Cre; Mettl3 fl/fl AGM ( Figure 1K ). Subsequently, the increased expression of Notch1 was observed at mRNA level ( Figure 1L ). Consistently, immunofluorescence results further showed that in wild-type embryos, Notch1 was only enriched in the endothelial cells but not in the emerging hematopoietic clusters, whereas the increased expression of Notch1 was observed in both endothelial cells and poorly formed hematopoietic clusters in the E10. In summary, we utilized Cre/LoxP system to generate the endothelial-specific knockout mice of Mettl3, and identified the indispensable function of Mettl3-mediated m 6 A modification in mouse definitive hematopoiesis. Mechanistically, endothelial expression of Mettl3 can methylate Notch1 mRNA and then lead to the repression of Notch activity during EHT. Interestingly, bioinformatics analysis showed that m 6 A peak near the stop codon of Notch1 mRNA can be recognized by Ythdf2 (Supplementary information, Figure S2G ), suggesting that Ythdf2-mediated Notch1 mRNA decay is responsible for the observed HSPC phenotype [10] . These results are consistent with our recent findings in zebrafish [7] , supporting an evolutionally conserved function of m 6 A in HSPC specification in mammals. In addition, three recent studies have demonstrated that mRNA m 6 A modification mediated by Mettl3/Mettl14 plays essential roles during spermatogenesis in mice [11] [12] [13] 
